Go Back April, 2026
Letters in Applied NanoBioScience

Synthesis of mesoionic 1-aryl-4-(phenyl/p-chilorophenyl)imidazo[2,1-b]thiazol-4-ones and study of theirmonoamine oxidase, succinate dehydrogenase inhibitory, anti-convulsant and anti-bacterial activity.

Details
Volume 12
Issue 3
Pages 90
Impact Metrics